What is a stock summary page? Click here for an overview.
Business Description
Haleon PLC
ISIN : US4055521003
Share Class Description:
MEX:HLN1: ADRCompare
Compare
Traded in other countries / regions
HLN.UKHLN.USAH6D0.GermanyHLN1.Mexico IPO Date
2022-07-25Description
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.22 | |||||
| Equity-to-Asset | 0.47 | |||||
| Debt-to-Equity | 0.63 | |||||
| Debt-to-EBITDA | 4.39 | |||||
| Interest Coverage | 5.6 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 2.83 | |||||
| Beneish M-Score | -2.53 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.8 | |||||
| 3-Year EBITDA Growth Rate | 11.2 | |||||
| 3-Year FCF Growth Rate | 23.4 | |||||
| 3-Year Book Growth Rate | -14.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 8.02 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 9-Day RSI | 0.01 | |||||
| 14-Day RSI | 0.44 | |||||
| 3-1 Month Momentum % | -7.92 | |||||
| 6-1 Month Momentum % | -7.92 | |||||
| 12-1 Month Momentum % | 32.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.98 | |||||
| Quick Ratio | 0.78 | |||||
| Cash Ratio | 0.38 | |||||
| Days Inventory | 112.04 | |||||
| Days Sales Outstanding | 54.98 | |||||
| Days Payable | 204.95 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.49 | |||||
| Dividend Payout Ratio | 0.38 | |||||
| Forward Dividend Yield % | 1.81 | |||||
| 5-Year Yield-on-Cost % | 1.49 | |||||
| 3-Year Average Share Buyback Ratio | 0.7 | |||||
| Shareholder Yield % | 3.83 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 60.75 | |||||
| Operating Margin % | 19.64 | |||||
| Net Margin % | 12.84 | |||||
| FCF Margin % | 18.87 | |||||
| ROE % | 8.76 | |||||
| ROA % | 4.25 | |||||
| ROIC % | 5.58 | |||||
| 3-Year ROIIC % | -70.86 | |||||
| ROC (Joel Greenblatt) % | 121.45 | |||||
| ROCE % | 8.07 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 24.83 | |||||
| Forward PE Ratio | 19.11 | |||||
| PE Ratio without NRI | 25.48 | |||||
| Price-to-Owner-Earnings | 16.31 | |||||
| PEG Ratio | 1.73 | |||||
| PS Ratio | 3.19 | |||||
| PB Ratio | 2.18 | |||||
| Price-to-Free-Cash-Flow | 18.05 | |||||
| Price-to-Operating-Cash-Flow | 15.53 | |||||
| EV-to-EBIT | 18.75 | |||||
| EV-to-Forward-EBIT | 19.52 | |||||
| EV-to-EBITDA | 18.75 | |||||
| EV-to-Forward-EBITDA | 17.07 | |||||
| EV-to-Revenue | 3.85 | |||||
| EV-to-Forward-Revenue | 3.74 | |||||
| EV-to-FCF | 21.78 | |||||
| Price-to-GF-Value | 1.18 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.48 | |||||
| Earnings Yield (Greenblatt) % | 5.33 | |||||
| FCF Yield % | 5.63 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Haleon PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil MXN) | 269,167.08 | ||
| EPS (TTM) (MXN) | 7.525 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 47.48 | ||
| 14-Day RSI | 0.44 | ||
| 14-Day ATR (MXN) | 0.02238 | ||
| 20-Day SMA (MXN) | 186 | ||
| 12-1 Month Momentum % | 32.86 | ||
| 52-Week Range (MXN) | 138.3 - 202.39 | ||
| Shares Outstanding (Mil) | 4,517.47 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Haleon PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Haleon PLC Stock Events
| Event | Date | Price (MXN) | ||
|---|---|---|---|---|
| No Event Data | ||||
Haleon PLC Frequently Asked Questions
What is Haleon PLC(MEX:HLN1)'s stock price today?
The current price of MEX:HLN1 is MXN186.00. The 52 week high of MEX:HLN1 is MXN202.39 and 52 week low is MXN138.30.
When is next earnings date of Haleon PLC(MEX:HLN1)?
The next earnings date of Haleon PLC(MEX:HLN1) is 2025-07-08 Est..
Does Haleon PLC(MEX:HLN1) pay dividends? If so, how much?
The Dividend Yield %  of Haleon PLC(MEX:HLN1) is 1.49% (As of Today), Highest Dividend Payout Ratio of Haleon PLC(MEX:HLN1) was 0.38. The lowest was 0.24. And the median was 0.29. The  Forward Dividend Yield % of Haleon PLC(MEX:HLN1) is 1.81%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers